Top compounds associated with response to AC131263.1


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA myricetin CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.16 0.0009
mRNA RG-108 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA prima-1 CTRPv2 pan-cancer AAC 0.1 0.001
mRNA methylstat CTRPv2 pan-cancer AAC 0.14 0.001
Download CSV